초록 ▼

Novel classes of multi-arm polyalkylene oxide-based materials including PEG nanocarriers, nanogel particles, and aggregated nanogel particles are disclosed. These classes of compositions may be associated with therapeutic agents and targeting moieties, or visibility enhancing agents, and may have a

Novel classes of multi-arm polyalkylene oxide-based materials including PEG nanocarriers, nanogel particles, and aggregated nanogel particles are disclosed. These classes of compositions may be associated with therapeutic agents and targeting moieties, or visibility enhancing agents, and may have a modified surface structure. In some embodiments the PEG-based materials can be made to provide relatively high drug loads with improved solubility and targeted delivery.

대표청구항 ▼

1. A nanocarrier, comprising two doxorubicin molecules (Dox) coupled to at least one end of a linear polyalkylene oxide or a four-arm polyalkylene oxide by the linker Glu(Leu-Gly)2 SEQ ID No: 1, wherein two or four Dox are coupled to said linear polyalkylene oxide and eight Dox are coupled to said f

1. A nanocarrier, comprising two doxorubicin molecules (Dox) coupled to at least one end of a linear polyalkylene oxide or a four-arm polyalkylene oxide by the linker Glu(Leu-Gly)2 SEQ ID No: 1, wherein two or four Dox are coupled to said linear polyalkylene oxide and eight Dox are coupled to said four-arm polyalkylene oxide. 2. The nanocarrier of claim 1, wherein four Dox are coupled to said linear polyalkylene oxide and eight Dox are coupled to said four-arm polyalkylene oxide. 3. The nanocarrier of claim 1, wherein the aqueous solubility is at least about 100 mg/ml. 4. The nanocarrier of claim 1, wherein the four-arm polyalkylene oxide is four-arm polyethylene glycol. 5. The nanocarrier of claim 1, further comprising a targeting moiety. 6. The nanocarrier of claim 5, wherein the targeting moiety is peptide. 7. The nanocarrier of claim 5, wherein the targeting moiety is selected from the group consisting of an RGD peptide, a DV3 peptide, a LYP peptide, a membrane binding domain of IGFBP3, fMLF, mannose, transferrin ligand, and a monoclonal antibody.